US Stock MarketDetailed Quotes

INZY Inozyme Pharma

Watchlist

5.400
+0.290+5.68%

Close Aug 23 16:00 ET

5.430
+0.030+0.56%

Post 20:01 ET

362.33MMarket Cap-3750P/E (TTM)

Inozyme Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inozyme Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	-- / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q3-- / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Inozyme Pharma Earnings Reports

Inozyme Pharma | 10-Q: Q2 2024 Earnings Report

Aug 6 08:43 ET

Inozyme Pharma | 10-Q: Q1 2024 Earnings Report

May 7 08:34 ET

Inozyme Pharma | 10-K: FY2023 Annual Report

Mar 12 08:37 ET

Inozyme Pharma | 10-Q: Q3 2023 Earnings Report

Nov 7, 2023 08:34 ET

Analyst Rating

Updated: Aug 13, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall